- Home
- COOK vs SLN Comparison
COOK vs SLN Comparison
Compare COOK & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- SLN
- Stock Information
- Founded
- COOK 1985
- SLN 1994
- Country
- COOK United States
- SLN United Kingdom
- Employees
- COOK 666
- SLN N/A
- Industry
- COOK Wholesale Distributors
- SLN Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- SLN Health Care
- Exchange
- COOK Nasdaq
- SLN Nasdaq
- Market Cap
- COOK 237.8M
- SLN 223.4M
- IPO Year
- COOK 2021
- SLN N/A
- Fundamental
- Price
- COOK $1.74
- SLN $4.11
- Analyst Decision
- COOK Hold
- SLN Buy
- Analyst Count
- COOK 6
- SLN 5
- Target Price
- COOK $2.83
- SLN $40.80
- AVG Volume (30 Days)
- COOK 176.1K
- SLN 234.1K
- Earning Date
- COOK 03-06-2025
- SLN 02-27-2025
- Dividend Yield
- COOK N/A
- SLN N/A
- EPS Growth
- COOK N/A
- SLN N/A
- EPS
- COOK N/A
- SLN N/A
- Revenue
- COOK $604,072,000.00
- SLN $43,258,000.00
- Revenue This Year
- COOK $6.07
- SLN N/A
- Revenue Next Year
- COOK $9.17
- SLN N/A
- P/E Ratio
- COOK N/A
- SLN N/A
- Revenue Growth
- COOK N/A
- SLN 36.71
- 52 Week Low
- COOK $1.71
- SLN $4.06
- 52 Week High
- COOK $3.97
- SLN $27.72
- Technical
- Relative Strength Index (RSI)
- COOK 21.91
- SLN 37.90
- Support Level
- COOK $1.82
- SLN $4.06
- Resistance Level
- COOK $2.42
- SLN $4.90
- Average True Range (ATR)
- COOK 0.14
- SLN 0.40
- MACD
- COOK -0.05
- SLN 0.02
- Stochastic Oscillator
- COOK 15.48
- SLN 15.57
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.